MedPath

CIMZIA

CIMZIA

Approved
DIN Number

02331675

Drug Class

Human

Market Date

Aug 31, 2009

Company
HC

UCB Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02331675
AIG Number0152646001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AB05 CERTOLIZUMAB PEGOL
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

CERTOLIZUMAB PEGOLActive
Strength: 200 MG / ML
Monograph: CERTOLIZUMAB PEGOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.